QBIO - Q BioMed Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
11/29/2018
11/29/2017
11/29/2016
11/29/2015
Total Revenue
0
0
-
-
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
3,286
3,238
3,100
1,314
598
Selling General and Administrative
4,641
5,782
9,272
5,032
354
Total Operating Expenses
7,927
9,020
12,372
6,347
952
Operating Income or Loss
-7,927
-9,020
-12,372
-6,347
-952
Interest Expense
1,299
162
760
480
15
Total Other Income/Expenses Net
-
-89
-1,410
-345
-120
Income Before Tax
-9,908
-9,271
-14,542
-7,172
-1,087
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-9,908
-9,271
-14,542
-7,172
-1,087
Net Income
-9,908
-9,271
-14,542
-7,172
-1,087
Net Income available to common shareholders
-9,908
-9,271
-14,542
-7,172
-1,087
Reported EPS
Basic
-
-0.67
-1.39
-0.81
-0.12
Diluted
-
-0.67
-1.39
-0.81
-0.12
Weighted average shares outstanding
Basic
-
13,735
10,467
8,861
9,068
Diluted
-
13,735
10,467
8,861
9,068
EBITDA
-
-9,109
-13,781
-6,691
-1,072